<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s0{border-right: none;background-color:#ffffff;text-align:left;font-weight:bold;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{border-left: none;background-color:#ffffff;}.ritz .waffle .s3{background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s6{border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'docs-Roboto',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s8{background-color:#ffffff;text-align:left;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#007bff;font-family:'docs--apple-system',Arial;font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s1{border-left: none;border-right: none;background-color:#ffffff;}.ritz .waffle .s4{border-right: none;background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s5{border-right: none;background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s7{background-color:#ffffff;text-align:left;color:#000000;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="1631030952C0" style="width:100px;" class="column-headers-background">A</th><th id="1631030952C1" style="width:100px;" class="column-headers-background">B</th><th id="1631030952C2" style="width:100px;" class="column-headers-background">C</th></tr></thead><tbody><tr style="height: 20px"><th id="1631030952R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Monochorionic Twins (MCDA and MCMA)</div></td><td class="s1"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s3" dir="ltr">Diagnosis</td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">1 in 3 twin pregnancies are monochorionic</div></td><td class="s1"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">10-15% of MC twin pregnancies (including mono-mono) are affected by TTTS</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">USS between 11+0 and 13+6 gestation (CRL 45-85mm)</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:898px;left:-1px">Features used to determine chorionicity: placental masses, membrane thickness and appearance of the membrane attachment to the placenta</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:898px;left:-1px">If there is diagnostic uncertainty, ensure appointment with specialist prior to 14 weeks mostly as this determines monitoring for TTTS and timing of birth</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s3" dir="ltr">Counselling</td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:998px;left:-1px">Parents should be informed of higher fetal loss rate in 2nd trimester and higher risk of neurodevelopmental conditionsn with monochorionic twins than dichorionic.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Monitor for sudden breathlessness / increased abdominal size (suggesting of TTTS)</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Screening for Chromosomal Abnormalities</div></td><td class="s1"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">Advise combined screening, if missed advised quadruple testing</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">NIPT not clearly evidenced yet</div></td><td class="s2"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Scanning Frequency</div></td><td class="s2"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Growth, LV, fetal bladders and UAPI every two weeks from 16 weeks</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">If TAPS suspected (ie following fetoscopic ablation or sIUGR) advise serial MCA PSV</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td class="s3" dir="ltr">Referral</td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">If EFW discordance is &gt;20% (using smaller twin as denominator), refer to fetal medicine</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R23" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">24</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R24" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">25</div></th><td class="s3" dir="ltr">Mx of TTTS</td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R25" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">26</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:598px;left:-1px">Use Quintero system for staging and serial growth / LV / UAPI / MCA PSV / ductus venosus</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R26" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">27</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Prior to 26 weeks, advise fetoscopic laser ablation using Solomon technique</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R27" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">28</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Deliver between 34+0 and 36+6</div></td><td class="s2"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R28" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">29</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1498px;left:-1px">Inform parents that in TTTS (even after apparently successful treatment) there can be acute transfusional events (which are neither predictable nor preventable) and therefore, despite regular monitoring, there may still be adverse perinatal outcomes.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R29" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">30</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">In severe TTTS presenting before 26 weeks laser ablation is preferred to amnioreduction or septostomy.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R30" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">31</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:798px;left:-1px">It may be reasonable to discuss TOP and selective TOP with the patient in the case of severe TTTS if the patient requests one.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R31" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">32</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R32" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">33</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Mx of sIUGR (aka sGR)</div></td><td class="s2"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R33" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">34</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Consider selective reduction if diagnosis early</div></td><td class="s1"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R34" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">35</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px">2-weekly growth scans, if UAPI abnormal measure DV</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R35" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">36</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:498px;left:-1px">Abnormal DV or reduced STV on compCTG triggers consideration of delivery</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R36" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">37</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:898px;left:-1px">In type I sGR, consider deliveryby 34–36 weeks of gestation if there is satisfactory fetal growth velocity and normal umbilical artery Doppler waveforms. </div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R37" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">38</div></th><td class="s6 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1098px;left:-1px">In type II and III sGR, delivery should be planned by 32 weeks of gestation, unless fetal growth velocity is significantly abnormal or there is worsening of the fetal Doppler assessment. </div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R38" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">39</div></th><td class="s6 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1198px;left:-1px">Inform parents that in sGR there can be acute transfusional events (which are neither predictable nor preventable) and therefore, despite regular monitoring, there may still be adverse perinatal outcomes.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R39" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">40</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R40" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">41</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Mx after fetal death:</div></td><td class="s2"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R41" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">42</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1298px;left:-1px">After a single fetal death in a monochorionic pregnancy, clinicians should be aware that the risks to the surviving twin of death or neurological abnormality are of the order of 15% and 26%, respectively. [New 2016]</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R42" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">43</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:998px;left:-1px">Single fetal death in a monochorionic pregnancy should be referred and assessed in a fetal medicine centre, with multidisciplinary expertise to manage these cases.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R43" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">44</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1198px;left:-1px">Fetal magnetic resonance imaging of the brain may be performed 4 weeks after co-twin demise to detect neurological morbidity if this information would be of value in planning management.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R44" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">45</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:698px;left:-1px">Fetal anaemia may be assessed by measurement of the fetal MCA PSV using Doppler ultrasonography</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R45" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">46</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R46" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">47</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Mx of uncomplicated MCDA pregnancy</div></td><td class="s1"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R47" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">48</div></th><td class="s4 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1298px;left:-1px">Women with monochorionic twins should have timing of birth discussed and be offered elective delivery from 36+0 weeks with the administration of antenatal steroids, unless there is an indication to deliver earlier. </div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R48" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">49</div></th><td class="s6 softmerge" dir="ltr"><div class="softmerge-inner" style="width:898px;left:-1px">It is appropriate to aim for vaginal birth of monochorionic diamniotic twins unless there are other specific clinical indications for caesarean section.</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R49" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">50</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R50" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">51</div></th><td class="s5 softmerge" dir="ltr"><div class="softmerge-inner" style="width:298px;left:-1px">Mx of uncomplicated MCMA pregnancy</div></td><td class="s1"></td><td class="s2"></td></tr><tr style="height: 20px"><th id="1631030952R51" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">52</div></th><td class="s6 softmerge" dir="ltr"><div class="softmerge-inner" style="width:998px;left:-1px">In monochorionic, monoamniotic twin pregnancy most develop cord entanglement and delivery by caesarian section is advised between 32 and 34 weeks</div></td><td class="s1"></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1631030952R52" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">53</div></th><td></td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R53" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">54</div></th><td class="s3" dir="ltr">Sources</td><td></td><td></td></tr><tr style="height: 20px"><th id="1631030952R54" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">55</div></th><td class="s7" dir="ltr">GTG</td><td class="s8" dir="ltr" colspan="2"><a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.14188/epdf">Green-top Guideline No. 51</a></td></tr></tbody></table></div>